≡

Recombinant Laminin Gamma 2 (LAMC2)

B2T; EBR2; EBR2A; LAMB2T; LAMNB2; Kalinin/nicein/epiligrin 100 kDa subunit; Cell-scattering factor 140 kDa subunit; Ladsin 140 kDa; Large adhesive scatter factor 140 kDa

  • Product No.RPC083Hu02
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted, Extracellular matrix
  • Predicted Molecular Mass55.5kDa
  • Accurate Molecular Mass56kDa(Analysis of differences refer to the manual)
  • Residues & TagsCys187~Pro415 with N-terminal His and GST Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 80%
  • Isoelectric Point8.4
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 140  US$ 350  US$ 700  US$ 2100  US$ 5250 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in ddH2O to a concentration of 0.1-0.2 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Molecular & Cellular Proteomics LAMC2: A promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues Mcponline: 023507
Clinical Cancer Research Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer Pubmed:25239611
British journal of cancer Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer PubMed: 26180921
U.S. National Library of Medicine Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer pubmed:27462170
American Journal of Obstetrics & Gynecology MFM PRETERM BIRTH PREDICTION IN ASYMPTOMATIC WOMEN AT MID-GESTATION USING A PANEL OF NOVEL PROTEIN BIOMARKERS: The Prediction of PreTerm …
Biomarkers of Preterm Birth
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC083Hu02 Recombinant Laminin Gamma 2 (LAMC2) Positive Control; Immunogen; SDS-PAGE; WB.
RPC083Hu05 Recombinant Laminin Gamma 2 (LAMC2) Positive Control; Immunogen; SDS-PAGE; WB.
RPC083Hu01 Recombinant Laminin Gamma 2 (LAMC2) Positive Control; Immunogen; SDS-PAGE; WB.
RPC083Hu03 Recombinant Laminin Gamma 2 (LAMC2) Positive Control; Immunogen; SDS-PAGE; WB.
PAC083Hu01 Polyclonal Antibody to Laminin Gamma 2 (LAMC2) WB; IHC; ICC; IP.
PAC083Hu03 Polyclonal Antibody to Laminin Gamma 2 (LAMC2) WB; IHC; ICC; IP.
PAC083Hu02 Polyclonal Antibody to Laminin Gamma 2 (LAMC2) WB; IHC; ICC; IP.
FAC083Hu01 Anti-Laminin Gamma 2 (LAMC2) Polyclonal Antibody Flow cytometry.
FAC083Hu03 Anti-Laminin Gamma 2 (LAMC2) Polyclonal Antibody Flow cytometry.
MAC083Hu22 Monoclonal Antibody to Laminin Gamma 2 (LAMC2) WB
MAC083Hu21 Monoclonal Antibody to Laminin Gamma 2 (LAMC2) WB
FAC083Hu02 Anti-Laminin Gamma 2 (LAMC2) Monoclonal Antibody Flow cytometry.
FAC083Hu04 Anti-Laminin Gamma 2 (LAMC2) Monoclonal Antibody Flow cytometry.
SEC083Hu ELISA Kit for Laminin Gamma 2 (LAMC2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC083Hu Multiplex Assay Kit for Laminin Gamma 2 (LAMC2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.